MYCN and neoplasm: An alteration in the tumor biology, such as the de novo observed MYCN amplification and 1p deletion, may have broken immunologic tolerance and generated antibodies against NB-expressed antigens, also expressed in the hippocampi (causing LE) and the myenteric plexus (producing CIPO).